Diabetes Research

Thrilled to represent Obesity Matters in the preparatory discussions for World Obesity Day on March 4th. This year’s theme, « Let’s Talk About Obesity and_____ » is incredibly relevant. Considering the myriad ways obesity is connected to mental health, diabetes, CVD, sleep disorders, nutrition, physical activity, policy, and especially its impact on youth, it’s crucial we initiate and broaden this important dialogue.

It was inspiring to witness global representation, with participants driven by a mission to shift the narrative and make a tangible difference in the lives of those living with this chronic condition.

As World Obesity Day approaches, let’s unite in our efforts to understand, empathize, and support those impacted by obesity. Together, we can break down barriers and bring about positive change.

🏎️💨 Vroom Vroom! Guess who rolled into the Maserati reception? Shoutout to for the invite and to for adding that sparkle of joy and . 💋♥️💋

Today held its first advisory board meeting of 2024. The discussions were vibrant and insightful, especially on the topic of access to treatment. Having advocates with lived experiences at the table brought unique and valuable perspectives, differentiating from traditional views.

This is what ignites our passion at OM - bringing patient voices to the forefront and challenging conventional norms. Their contributions are essential in shaping our direction and future projects. Stay tuned for exciting initiatives and events on the horizon! 🚀

I’m immensely grateful for our incredible team of advisors and directors, whose strategic guidance is invaluable. 💪

We hosted an important , bringing together varied voices to push for enhanced reimbursement strategies for obesity treatments.

Thankful for all the support as we advance towards better healthcare, one step at a time. 🙏

🤩 Standing in awe in front of the magnificent 'R-Evolution' by Marco Cochrane on Lincoln Road, Miami.

From the desert of 🔥to the vibrant streets of Miami, a giant steel woman making a grand entrance on Lincoln Road, just in time for !

🌟 What an enlightening day it's been! Attended the conference focused on advancing clinical trials - from strategy acceleration across Canada to groundbreaking work in rare diseases and designing inclusive studies for vulnerable groups. Proud to represent ObesityMatters, showcasing the critical role of advocates in research design and participant recruitment.

But the highlight? The inspiring keynote by Chika Stacy Oriuwa on 'The Path to Improved Diversity in Canadian Clinical Trials.' Her personal journey of discrimination to becoming a was nothing short of empowering. 👏

And since we both share the deepest respect for , we just had to strike a Sean-like pose!

🌟 Today, we proudly represented Obesity Matters at "The Next Era of Healthcare in Canada: Cross-Sector Collaboration and the Power of Partnership" event hosted by Lilly Canada & The Economic Club of Canada marking the dual milestones of Lilly Canada's 85th anniversary and the 100th year since Lilly's collaboration with the University of Toronto, a partnership that was instrumental in bringing insulin to the global stage.

The panel was a powerhouse of insights with Andre Picard, Jane Barratt, Dr. Mark Lachman, Dave Ricks, and the inspiring Hon. Lisa Raitt, whose heartfelt journey as a caregiver for her husband with early-stage Alzheimer's showed the raw side of health struggles that resonated deeply with us. The discussion highlighted the critical role of long-term care, advocacy activation, and strong partnerships in healthcare. 💚

🚀

We had an incredible interactive session discussing anti-obesity meds! 📚💡 So honoured to be surrounded by such knowledgeable experts 🎓✨. The energy was palpable with a chat box overflowing with insightful questions & comments 🗨️🔍.

A huge shoutout and thanks 🙏 to everyone for your unwavering commitment to this workshop and Obesity Matters. Dr. Megha Poddar joined us from a remote island in BC while Dr. Florencia Ziemke was tackling Hurricane Idalia! Your invaluable insights will undeniably propel the dialogue on obesity treatments and care forward. 🚀🌍

Research centres in Canada are conducting clinical trials exploring the efficacy and safety of an investigational medication in participants with type 2 diabetes compared to other existing treatment options when treatment is initiated early.

Eligibility:
• Been diagnosed with type 2 diabetes within the last 4 years
• Have HbA1c value between ≥ 7.0% and ≤9.5%
• Have been on a stable metformin treatment for at least 3 months before entering the study.

Qualified participants will receive no-cost study medication, study-related care and up to $1,350 in reimbursement.

If you would like to learn more about this opportunity, connect with us today!
Tel: 1-877-885-0808

A Canadian research centre is conducting an online research survey to understand the current health and quality of life, as well as treatment preferences for people with diabetes and toenail fungus (also called onychomycosis).

Eligible subjects will be compensated for their time.

A Canadian research centre is conducting an online research survey to understand the current health and quality of life for people with diabetes and toenail fungus (also called onychomycosis), as well as their preferences for different toenail fungus treatments.

Eligibility:
• Adult (aged ≥18 years old) living in Canada
• Diagnosed with type I or type II diabetes
• Having an active toenail fungus infection, or an infection that has been cured in the last three months
• Able to read English fluently
• Access to a desktop or laptop computer (preferred), or tablet (phones will not work)

Eligible subjects will be compensated for their time.

Survey link: https://toenailfungusdce.broadstreetheor.com/